Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] NLMUID: 8707234"" wg kryterium: JN

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 9764
Tytuł:
Meta-analysis: The impact of light-to-moderate alcohol consumption on progressive non-alcoholic fatty liver disease.
Autorzy:
Magherman L; Hepatology Research Unit, Dpt. Internal Medicine and Pediatrics, Liver Research Center Ghent, Ghent University, Ghent, Belgium.
Van Parys R; Hepatology Research Unit, Dpt. Internal Medicine and Pediatrics, Liver Research Center Ghent, Ghent University, Ghent, Belgium.
Pauwels NS; Knowledge Center for Health Ghent, Ghent University and Ghent University Hospital, Ghent, Belgium.
Verhelst X; Hepatology Research Unit, Dpt. Internal Medicine and Pediatrics, Liver Research Center Ghent, Ghent University, Ghent, Belgium.
Devisscher L; Gut-Liver Immunopharmacology Unit, Department of Basic and Applied Medical Sciences, Liver Research Center Ghent, Ghent University, Ghent, Belgium.
Van Vlierberghe H; Hepatology Research Unit, Dpt. Internal Medicine and Pediatrics, Liver Research Center Ghent, Ghent University, Ghent, Belgium.
Geerts A; Hepatology Research Unit, Dpt. Internal Medicine and Pediatrics, Liver Research Center Ghent, Ghent University, Ghent, Belgium.
Lefere S; Hepatology Research Unit, Dpt. Internal Medicine and Pediatrics, Liver Research Center Ghent, Ghent University, Ghent, Belgium.; Gut-Liver Immunopharmacology Unit, Department of Basic and Applied Medical Sciences, Liver Research Center Ghent, Ghent University, Ghent, Belgium.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 820-836. Date of Electronic Publication: 2023 Jan 27.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular*
Liver Neoplasms*/etiology
Non-alcoholic Fatty Liver Disease*/epidemiology
Humans ; Alcohol Drinking/adverse effects ; Cross-Sectional Studies ; Fibrosis ; Liver Cirrhosis/etiology ; Liver Cirrhosis/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Meta-analysis: Placebo rates in microscopic colitis randomised trials and applications for future drug development using a historical control arm.
Autorzy:
Hamilton P; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Buhler K; Division of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
MacDonald JK; Alimentiv Inc., London, Ontario, Canada.
Kaplan GG; Division of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Seow CH; Division of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Lu C; Division of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Novak KL; Division of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Andrews CN; Division of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Singh S; Division of Gastroenterology, University of California San Diego, San Diego, California, USA.
Jairath V; Alimentiv Inc., London, Ontario, Canada.; Division of Gastroenterology, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.
Panaccione R; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Ma C; Division of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.; Alimentiv Inc., London, Ontario, Canada.; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 837-850. Date of Electronic Publication: 2023 Feb 24.
Typ publikacji:
Meta-Analysis; Journal Article; Review
MeSH Terms:
Colitis, Microscopic*/drug therapy
Colitis, Collagenous*/drug therapy
Adult ; Humans ; Budesonide/therapeutic use ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Review article: Functional dyspepsia-a gastric disorder, a duodenal disorder or a combination of both?
Autorzy:
Broeders BWLCM; Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium.; Faculty of Medicine, KU Leuven, Leuven, Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium.
Carbone F; Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium.; Faculty of Medicine, KU Leuven, Leuven, Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium.
Balsiger LM; Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium.
Schol J; Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium.; Faculty of Medicine, KU Leuven, Leuven, Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium.
Raymenants K; Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium.; Faculty of Medicine, KU Leuven, Leuven, Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium.
Huang I; Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium.
Verheyden A; Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium.
Vanuytsel T; Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium.; Faculty of Medicine, KU Leuven, Leuven, Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium.
Tack J; Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium.; Faculty of Medicine, KU Leuven, Leuven, Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 851-860. Date of Electronic Publication: 2023 Mar 01.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Dyspepsia*/drug therapy
Dyspepsia*/diagnosis
Duodenal Diseases*
Eosinophilia*/complications
Humans ; Duodenum ; Eosinophils
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Randomised clinical trial: Psychological intervention improves work productivity and daily activity by reducing abdominal pain and fatigue in Crohn's disease.
Autorzy:
Regev S; Department of Social Work, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Schwartz D; Department of Gastroenterology and Hepatology, Soroka Medical Center, Beer-Sheva, Israel.
Sarid O; Department of Social Work, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Goren G; Department of Social Work, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Slonim-Nevo V; Department of Social Work, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Friger M; Department of Public Health, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Sergienko R; Department of Public Health, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Greenberg D; Department of Health Systems Management, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Monsonego A; Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Nemirovsky A; Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Odes S; Division of Clinical Medicine, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 861-871. Date of Electronic Publication: 2023 Feb 02.
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Crohn Disease*/complications
Crohn Disease*/drug therapy
Humans ; Female ; Male ; Psychosocial Intervention ; Abdominal Pain/drug therapy ; Abdominal Pain/etiology ; Fatigue/etiology ; Fatigue/therapy ; Israel ; Quality of Life
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Secondary bile acids improve risk prediction for non-invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease.
Autorzy:
Liu AN; National Clinical Research Center for Child Health, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Xu CF; National Clinical Research Center for Child Health, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Liu YR; National Clinical Research Center for Child Health, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Sun DQ; Department of Nephrology, The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, China.; Affiliated Wuxi Clinical College of Nantong University, Wuxi, China.
Jiang L; National Clinical Research Center for Child Health, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Tang LJ; NAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Zhu PW; Department of Laboratory Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Chen SD; Department of Pathology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Liu WY; Department of Endocrinology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Wang XD; Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, China.
Targher G; Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Verona, Verona, Italy.
Byrne CD; Southampton National Institute for Health and Care Research Biomedical Research Centre, University Hospital Southampton & University of Southampton, Southampton General Hospital, Southampton, UK.
Wong VW; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China.
Fu J; National Clinical Research Center for Child Health, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Su MM; Clinical Mass Spectrometry Innovation Center, Shanghai Keyi Biotechnology Co., Ltd., Shanghai, China.
Loomba R; NAFLD Research Center, Division of Gastroenterology, University of California, San Diego, La Jolla, California, USA.
Zheng MH; NAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.; Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, China.; Institute of Hepatology, Wenzhou Medical University, Wenzhou, China.
Ni Y; National Clinical Research Center for Child Health, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 872-885. Date of Electronic Publication: 2023 Jan 20.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/complications
Adult ; Male ; Humans ; Female ; Bile Acids and Salts ; Liver Cirrhosis/complications ; Inflammation/complications ; Biomarkers ; Obesity/complications ; Liver/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Potential benefit and lack of serious risk from corticosteroids in drug-induced liver injury: An international, multicentre, propensity score-matched analysis.
Autorzy:
Niu H; Servicios de Aparato Digestivo y Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Universidad de Málaga, Málaga, Spain.; Biomedical Research Network Center for Hepatic and Digestive Diseases (CIBERehd), Carlos III Health Institute, Madrid, Spain.; Platform for Clinical Research and Clinical Trials IBIMA, Plataforma ISCIII de Investigación Clínica, Madrid, Spain.
Ma J; Division of Gastroenterology/Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Medina-Caliz I; Servicios de Aparato Digestivo y Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Universidad de Málaga, Málaga, Spain.
Robles-Diaz M; Servicios de Aparato Digestivo y Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Universidad de Málaga, Málaga, Spain.; Biomedical Research Network Center for Hepatic and Digestive Diseases (CIBERehd), Carlos III Health Institute, Madrid, Spain.
Bonilla-Toyos E; Servicios de Aparato Digestivo y Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Universidad de Málaga, Málaga, Spain.; Platform for Clinical Research and Clinical Trials IBIMA, Plataforma ISCIII de Investigación Clínica, Madrid, Spain.
Ghabril M; Division of Gastroenterology/Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Lucena MI; Servicios de Aparato Digestivo y Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Universidad de Málaga, Málaga, Spain.; Biomedical Research Network Center for Hepatic and Digestive Diseases (CIBERehd), Carlos III Health Institute, Madrid, Spain.; Platform for Clinical Research and Clinical Trials IBIMA, Plataforma ISCIII de Investigación Clínica, Madrid, Spain.
Alvarez-Alvarez I; Servicios de Aparato Digestivo y Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Universidad de Málaga, Málaga, Spain.; Biomedical Research Network Center for Hepatic and Digestive Diseases (CIBERehd), Carlos III Health Institute, Madrid, Spain.; Platform for Clinical Research and Clinical Trials IBIMA, Plataforma ISCIII de Investigación Clínica, Madrid, Spain.
Andrade RJ; Servicios de Aparato Digestivo y Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Universidad de Málaga, Málaga, Spain.; Biomedical Research Network Center for Hepatic and Digestive Diseases (CIBERehd), Carlos III Health Institute, Madrid, Spain.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 886-896. Date of Electronic Publication: 2022 Dec 22.
Typ publikacji:
Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Liver Failure, Acute*/etiology
Chemical and Drug Induced Liver Injury*/diagnosis
Chemical and Drug Induced Liver Injury*/epidemiology
Chemical and Drug Induced Liver Injury*/etiology
Humans ; Propensity Score ; Adrenal Cortex Hormones/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of malnutrition and nutrition support in hospitalised patients with inflammatory bowel disease.
Autorzy:
Dua A; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Corson M; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.; Center for Inflammatory Bowel Diseases, Vatche & Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Sauk JS; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.; Center for Inflammatory Bowel Diseases, Vatche & Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Jaffe N; Center for Inflammatory Bowel Diseases, Vatche & Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Limketkai BN; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.; Center for Inflammatory Bowel Diseases, Vatche & Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 897-906. Date of Electronic Publication: 2023 Jan 13.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Inflammatory Bowel Diseases*/complications
Inflammatory Bowel Diseases*/therapy
Malnutrition*/epidemiology
Malnutrition*/therapy
Malnutrition*/complications
Crohn Disease*/complications
Crohn Disease*/therapy
Colitis, Ulcerative*/complications
Colitis, Ulcerative*/therapy
Humans ; Health Care Costs
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Editorial: Interdisciplinary and multidisciplinary approach to malnutrition in patients with inflammatory bowel disease.
Autorzy:
Speedy AP; Department of Nutrition and Dietetics, Christchurch Hospital, Christchurch, New Zealand.
Wall CL; Department of Nutrition and Dietetics, Christchurch Hospital, Christchurch, New Zealand.; Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 907-908.
Typ publikacji:
Editorial; Research Support, Non-U.S. Gov't; Comment
MeSH Terms:
Malnutrition*/diagnosis
Malnutrition*/etiology
Inflammatory Bowel Diseases*/complications
Inflammatory Bowel Diseases*/therapy
Humans
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Editorial: risankizumab - ready to break ceilings?
Autorzy:
Ferrante M; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 909-910.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Antibodies, Monoclonal*/therapeutic use
Psoriasis*/drug therapy
Humans
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Editorial: risankizumab - ready to break ceilings? author's reply.
Autorzy:
Fumery M; Department of Gastroenterology, Amiens University Hospital, PeriTox, Université de Picardie, Amiens, France.
Peyrin-Biroulet L; Department of Gastroenterology, Inserm NGERE U1256, Nancy University Hospital, University of Lorraine, Vandoeuvre-lès-Nancy, France.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 911.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Antibodies, Monoclonal*/therapeutic use
Humans
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Editorial: deja vu all over again - let the P-CAB wars begin. Authors' reply.
Autorzy:
Hwang I; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
Lee S; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 914-915.
Typ publikacji:
Editorial; Comment
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Letter: be careful of gastrointestinal CMV infection in adverse events from ICIs therapy in solid tumours.
Autorzy:
Parente P; Pathology Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, FG, Italy.
Ascani S; Pathology Unit, Azienda Ospedaliera Santa Maria di Terni, University of Perugia, Terni, Italy.
Maiorano BA; Oncology Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, FG, Italy.
Zanelli M; Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Ciardiello D; Medical Oncology Unit, Department of Precision Medicine, 'Luigi Vanvitelli' University of Campania, Naples, Italy.; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 916-917.
Typ publikacji:
Letter; Comment
MeSH Terms:
Gastrointestinal Diseases*
Neoplasms*/drug therapy
Communicable Diseases*
Cytomegalovirus Infections*
Humans
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Letter: be careful of gastrointestinal CMV infection in adverse event from ICIs therapy in solid tumours-Authors' reply.
Autorzy:
Dahl E; Department of Gastroenterology, Copenhagen University Hospital, Herlev, Denmark.
Abed O; Department of Gastroenterology, Odense University Hospital, Odense, Denmark.; Research Unit of Medical Gastroenterology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Agnholt J; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Bjerrum J; Department of Gastroenterology, Copenhagen University Hospital, Herlev, Denmark.
Dige A; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Kjeldsen J; Department of Gastroenterology, Odense University Hospital, Odense, Denmark.; Research Unit of Medical Gastroenterology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Svane I; Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
Donia M; Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
Seidelin J; Department of Gastroenterology, Copenhagen University Hospital, Herlev, Denmark.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 918-919.
Typ publikacji:
Letter; Comment
MeSH Terms:
Gastrointestinal Diseases*
Neoplasms*/drug therapy
Communicable Diseases*
Cytomegalovirus Infections*/diagnosis
Cytomegalovirus Infections*/drug therapy
Humans
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Letter: should we abandon FIB-4 to characterise non-invasively patients with NAFLD?
Autorzy:
Pugliese N; Division of Internal Medicine and Hepatology, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano (MI), Italy.
Franchellucci G; Division of Internal Medicine and Hepatology, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano (MI), Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy.
Viganò M; Gastroenterology, Hepatology and Transplantation Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 920-921.
Typ publikacji:
Letter; Comment
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/diagnosis
Humans ; Risk Factors ; Liver Cirrhosis
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Letter: should we abandon FIB-4 to characterise noninvasively patients with NAFLD? Authors' reply.
Autorzy:
Henry L; Inova Medicine, Inova Health System, Falls Church, Virginia, USA.; Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia, USA.; Center for Liver Diseases, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia, USA.; Center for Outcomes Research in Liver Diseases, Washington, District of Columbia, USA.
Younossi Z; Inova Medicine, Inova Health System, Falls Church, Virginia, USA.; Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia, USA.; Center for Liver Diseases, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia, USA.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 922-923.
Typ publikacji:
Letter; Comment
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/diagnosis
Humans ; Risk Factors ; Liver Cirrhosis
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Letter: Low to moderate alcohol intake and progression of non-alcoholic fatty liver disease.
Autorzy:
Gu P; Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei, P. R. China.
Liu Y; Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei, P. R. China.
Wei S; Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei, P. R. China.
Chen M; Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei, P. R. China.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 924-925.
Typ publikacji:
Letter; Comment
MeSH Terms:
Non-alcoholic Fatty Liver Disease*
Humans ; Alcohol Drinking/adverse effects ; Liver
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Letter: dietitians are more than coaches.
Autorzy:
Gibson PR; Department of Gastroenterology, Central Clinical School, Monash University, Melbourne, Australia.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 926-927.
Typ publikacji:
Letter; Comment
MeSH Terms:
Nutritionists*
Humans ; Surveys and Questionnaires ; Health Knowledge, Attitudes, Practice
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Meta-analysis: Enhanced liver fibrosis test to identify hepatic fibrosis in chronic liver diseases.
Autorzy:
Hinkson A; Leeds Liver Unit, St James' University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK.; Leeds Liver Research Group, University of Leeds, Leeds, UK.; Leeds Institute for Medical Research, University of Leeds, Leeds, UK.
Lally H; School of Medicine, University of Leeds, Leeds, UK.
Gibson H; School of Medicine, University of Leeds, Leeds, UK.
Jones R; Leeds Liver Unit, St James' University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Rowe IA; Leeds Liver Unit, St James' University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK.; Leeds Liver Research Group, University of Leeds, Leeds, UK.; Leeds Institute for Medical Research, University of Leeds, Leeds, UK.
Shinkins B; Test Evaluation Group, Leeds Institute for Health Sciences, University of Leeds, Leeds, UK.
Parker R; Leeds Liver Unit, St James' University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK.; Leeds Liver Research Group, University of Leeds, Leeds, UK.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (7), pp. 750-762. Date of Electronic Publication: 2023 Jan 17.
Typ publikacji:
Meta-Analysis; Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/diagnosis
Non-alcoholic Fatty Liver Disease*/pathology
Elasticity Imaging Techniques*
Humans ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/pathology ; Liver/pathology ; Liver Function Tests ; Biopsy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Randomised clinical trial: Safety, tolerability, pharmacodynamics and pharmacokinetics of zastaprazan (JP-1366), a novel potassium-competitive acid blocker, in healthy subjects.
Autorzy:
Hwang I; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
Ji SC; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
Oh J; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
Kim H; Onconic Therapeutics Inc., Seoul, Republic of Korea.
Cha H; Onconic Therapeutics Inc., Seoul, Republic of Korea.
Kim J; Onconic Therapeutics Inc., Seoul, Republic of Korea.
Lee CS; Jeil Pharmaceutical CO., LTD., Seoul, Republic of Korea.
Yu KS; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
Lee S; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (7), pp. 763-772. Date of Electronic Publication: 2023 Feb 02.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Potassium*
Esomeprazole*
Humans ; Male ; Healthy Volunteers ; Double-Blind Method ; Gastrins ; Dose-Response Relationship, Drug ; Administration, Oral
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 9764

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies